Analysen von James D. Gordon
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 18.10.12 | Actelion overweight | J.P. Morgan Cazenove |
DAX 24.426 +1,3%ESt50 5.656 +1,3%MSCI World 4.330 +0,2%Top 10 Crypto 16,34 +0,2%Nas 22.755 +0,4%Bitcoin 100.964 +0,0%Euro 1,1760 +0,2%Öl 65,23 -0,3%Gold 3.876 +0,3%
Suche...